Wang D, Wu J, Guo Q, Li Z, et al. Ivarmacitinib ointment for the treatment of adults with mild-to-moderate atopic dermatitis: phase 3 part of a randomized, double-blind, placebo-controlled, phase 2/3 clinical trial. Br J Dermatol 2025 Nov 29:ljaf482. doi: 10.1093.
PMID: 41317338